Sex dimorphisms in the cognitive-enhancing action of the Alzheimer's drug donepezil in aged Rhesus monkeys

Neuropharmacology

Volumn 44, Issue 3, 2003, Pages 381-389

  Buccafusco, J J ^a   Jackson, W J ^a   Stone, J D ^a   Terry Jr , A V ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Aging; Cholinesterase inhibitor; Delayed response task; Memory; Non human primate; Sex differences

Indexed keywords

ACETYLCHOLINESTERASE; DONEPEZIL; NOOTROPIC AGENT;

ACCURACY; AGED; ALZHEIMER DISEASE; AMNESIA; ANIMAL EXPERIMENT; ARTICLE; CHOLINESTERASE INHIBITION; COGNITIVE DEFECT; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; DRUG RESPONSE; FEMALE; MALE; MEMORY; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; SEX DIFFERENCE; TASK PERFORMANCE;

EID: 0037371594     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(02)00378-7     Document Type: Article

References (34)

1. Bartolomeo A.C., Morris H., Buccafusco J.J., Kille N., Rosenzweig-Lipson S., Husbands M.G., Sabb A.L., Abou-Gharbia M., Moyer J.A., Boast C.A. The preclinical pharmacological profile of WAY-132983, a potent M1 Preferring Agonist. Journal of Pharmacology and Experimental Therapeutics. 292:2000;584-596.
2. Bartus R.T. On neurodegenerative diseases, models, and treatment strategies: Lessons learned and lessons forgotten a generation following the cholinergic hypothesis. Experimental Neurology. 163:2000;495-529.
3. Bontempi B., Whelan K.T., Risbrough V.B., Rao T.S., Buccafusco J.J., Lloyd G.K., Menzaghi F. SIB-1553A, (±)-4-{[2-(1-methyl-2-pyrrolidinyl)ethyl]thio}phenol hydrochloride, a subtype-selective ligand for nicotine acetylcholine receptors with putative cognitive-enhancing properties: Effects on working and reference memory performances in aged rodents and non-human primates. Journal of Pharmacology and Experimental Therapeutics. 299:2001;297-306.
4. Buccafusco J.J., Prendergast M., Terry A.V. Jr., Jackson W.J. Cognitive effects of nicotinic cholinergic agonists in non-human primates. Drug Development Research. 38:1996;196-203.
5. Buccafusco J.J., Jackson W.J., Jonnala R.R., Terry A.V. Jr. Differential improvement in memory-related task performance to nicotine by aged male and female rhesus monkeys. Behavioral Pharmacology. 10:1999;681-690.
6. Buccafusco J.J., Terry A.V. Jr. Multiple CNS targets for eliciting beneficial effects on memory and cognition. Journal of Pharmacology and Experimental Therapeutics. 295:2000;438-446.
7. Buccafusco J.J., Terry A.V.T. Jr. Nicotine and cognition in young and aged non-human primates. Levin E. Nicotine and the Nervous System. 2002;179-197 CRC Press, New York.
8. Chiari A., Tobin J.R., Pan H.L., Hood D.D., Eisenach J.C. Sex differences in cholinergic analgesia I: a supplemental nicotinic mechanism in normal females. Anesthesiology. 91:1999;1447-1454.
9. Daniel J.M., Roberts S.L., Dohanich G.P. Effects of ovarian hormones and environment on radial maze and water maze performance of female rats. Physiology and Behavior. 66:1999;11-20.
10. Elrod K., Buccafusco J.J., Jackson W.J. Nicotine enhances delayed matching-to-sample performance by primates. Life Sciences. 43:1988;277-287.
11. Fader A.J., Hendricson A.W., Dohanich G.P. Estrogen improves performance of reinforced T-maze alternation and prevents the amnestic effects of scopolamine administered systemically or intrahippocampally. Neurobiology of Learning and Memory. 69:1998;225-240.
12. Irle E., Kessler J., Markowitsch H.J. Primate learning tasks reveal strong impairments in patients with presenile or senile dementia of the Alzheimer type. Brain and Cognition. 6:1987;429-449.
13. Isacson O., Seo H., Lin L., Albeck D., Granholm A.C. Alzheimer's disease and Down's syndrome: roles of APP, trophic factors and ACh. Trends in Neurosciences. 25:2002;79-84.
14. Jackson W.J., Buccafusco J.J., Terry A.V. Jr., Rush D.K., Turk D.J. Velnacrine maleate improves delayed matching to sample performance by aged monkeys. Psychopharmacology. 119:1995;391-398.
15. Koyly E., Demirgoren S., London E.D., Pogun S. Sex differences in up-regulation of nicotinic acetylcholine-receptors in rat brain. Life Sciences. 61:1997;PL184-PL190.
16. Lavand'homme P.M., Eisenach J.C. Sex differences in cholinergic analgesia II: differing mechanisms in two models of allodynia. Anesthesiology. 91:1999;1455-1461.
17. Lloyd G.K., Williams M. Neuronal nicotinic acetylcholine receptors as novel drug targets. Journal of Pharmacology and Experimental Therapeutics. 292:2000;461-467.
18. Lucey J.V., O'Keane V., O'Flynn K., Clare A.W., Dinan T.G. Gender and age differences in the growth hormone response to pyridostigmine. International Clinical Psychopharmacology. 6:1991;105-109.
19. MacGowan S.H., Wilcock G.K., Scott M. Effect of gender and apolipoprotein E genotype on response to anticholinesterase therapy in Alzheimer's disease. International Journal of Geriatric Psychiatry. 13:1998;625-630.
20. Mochizuki T., Villemagne V.L., Scheffel U., Dannals R.F., Finley P., Zhan Y., Wagner H.N. Jr., Musachio J.L. Nicotine induced up-regulation of nicotinic receptors in CD-1 mice demonstrated with an in vivo radiotracer: gender differences. Synapse. 30:1998;116-118.
21. Overstreet D.H., Russell R.W., Kerni W., Netherton R.A. The influence of ovariectomy on the sex-dependent effects of the anticholinesterase diisopropylflurophosphate. Psychopharmacology. 74:1981;391-392.
22. Paule M.G., Bushnell P.J., Maurissen J.P.J., Wenger G.R., Buccafusco J.J., Chelonis J.J., Elliott R. Symposium overview: the use of delayed matching-to-sample procedures in studies of short-term memory in animals and humans. Neurotoxicology and Teratology. 20:1998;493-502.
23. Packard M.G., Teather L.A. Intra-hippocampal estradiol infusion enhances memory in ovariectomized rats. NeuroReport. 8:1997;3009-3013.
24. Packard M.G., Teather L.A. Posttraining estradiol injections enhance memory in ovariectomized rats: cholinergic blockade and synergism. Neurobiology of Learning and Memory. 68:1997;172-188.
25. Pearson V.E. Galantamine: a new Alzheimer drug with a past life. Annals of Pharmacotherapy. 35:2001;1406-1413.
26. Prendergast M.A., Jackson W.J., Terry A.V. Jr., Kille N.J., Arneric S.P., Buccafusco J.J. Age-related: differences in distractibility and response to methylphenidate in monkeys. Cerebral Cortex. 8:1998;164-172.
27. Rigaud A.S., Traykov L., Caputo L., Guelfi M.C., Latour F., Couderc R., Moulin R., de Rotrou J., Forette F., Boller F. The apolipoprotein E epsilon-4 allele and the response to tacrine therapy in Alzheimer's disease. European Journal of Neurology. 7:2000;255-258.
28. Roberts J.A., Gilardi K.V., Lasley B., Rapp P.R. Reproductive senescence predicts cognitive decline in aged female monkeys. NeuroReport. 8:1997;2047-2051.
29. Russell R.S., Overstreet D.H., Netherton R.A. Sex-linked and other genetic factors in the development of tolerance to the anticholinesterase, DFP. Neuropharmacology. 22:1983;75-81.
30. Sarter M., Turchi J. Age- and dementia-associated impairments in divided attention: psychological constructs, animal models, and underlying neuronal mechanisms. Dementia and Geriatric Cognitive Disorders. 13:2002;46-58.
31. Squire L.R., Zola-Morgan S., Chen K.S. Human amnesia and animal models of amnesia: Performance of amnesic patients on tests designed for the monkey. Behavioral Neuroscience. 102:1988;210-221.
32. Terry A.V. Jr., Buccafusco J.J., Prendergast M.A. Dose-specific improvements in memory-related task performance by rats and aged monkeys administered the nicotinic-cholinergic antagonist mecamylamine. Drug Development Research. 47:1999;127-136.
33. Wang R.H., Bejar C., Weinstock M. Gender differences in the effect of rivastigmine on brain cholinesterase activity and cognitive function in rats. Neuropharmacology. 39:2000;497-506.
34. Wenk G.L., Willard L.B. The neural mechanisms underlying cholinergic cell death within the basal forebrain. International Journal of Developmental Neuroscience. 16:1998;729-735.